You are here

Home

Clinical Trials: Musculoskeletal Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, February 26, 2013 - 12:00
Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy.
Conditions:   Muscular Dystrophy;   Duchenne Muscular Dystrophy,
Intervention:   Biological: Stem Cell
Sponsor:   Chaitanya Hospital, Pune
Recruiting - verified September 2014
Posted: Friday, February 22, 2013 - 12:00
Use of Cell Therapy to Enhance Arthroscopic Knee Cartilage Surgery
Condition:   Articular Cartilage Defect Grade III or IV of the Knee
Interventions:   Procedure: Autologous Cell;   Procedure: Standard microfracture arthroscopic surgery
Sponsors:   Fondren Orthopedic Group L.L.P.;   InGeneron, Inc.
Recruiting - verified August 2015
Posted: Friday, September 28, 2012 - 12:00
Autologous Adipose-Derived Stromal Cells Delivered Intra-articularly in Patients With Osteoarthritis.
Condition:   Osteoarthritis
Interventions:   Procedure: Liposuction with Local Anesthesia;   Biological: Intra articular infusion of AD-SVF
Sponsor:   Ageless Regenerative Institute
Recruiting - verified April 2016
Posted: Monday, July 16, 2012 - 12:00
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration
Condition:   Lumbar Intervertebral Disc Degeneration
Intervention:   Procedure: Autologous Adipose Tissue derived MSCs Transplantation
Sponsors:   Biostar;   Korea University Anam Hospital
Recruiting - verified March 2014
Posted: Tuesday, May 22, 2012 - 12:00
Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head
Condition:   Avascular Necrosis of Femur Head
Interventions:   Biological: XCEL-MT-OSTEO-ALPHA;   Procedure: Standard treatment
Sponsors:   Banc de Sang i Teixits;   Ministerio de Sanidad, Servicios Sociales e Igualdad;   Ministerio de Ciencia e Innovación, Spain;   European Regional Development Fund
Recruiting - verified November 2015
Posted: Monday, May 21, 2012 - 12:00
BOTOX® Treatment in Pediatric Lower Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Interventions:   Biological: botulinum toxin Type A;   Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Intervention:   Biological: botulinum toxin Type A
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
BOTOX® Treatment in Pediatric Upper Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Interventions:   Biological: botulinum toxin Type A;   Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Intervention:   Biological: botulinum toxin Type A
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Thursday, March 8, 2012 - 12:00
Safety Study of Mesenchymal Stem Cells and Spinal Fusion
Conditions:   Lumbar Spondylolisthesis Involving L4-L5, and/or;   Degenerative Discopathy Involving L4-L5
Interventions:   Biological: XCEL-MT-OSTEO-ALPHA;   Procedure: Standard treatment
Sponsors:   Banc de Sang i Teixits;   TFS Trial Form Support;   Ministerio de Sanidad, Servicios Sociales e Igualdad;   Ministerio de Ciencia e Innovación, Spain
Recruiting - verified November 2015

Pages